Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-12-19
1999-07-20
Owens, Amelia
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514456, 549407, 549437, A61K 3136, A61K 3135
Patent
active
059256737
ABSTRACT:
Methods for treating inflammnatory pathologies are disclosed. Particularly, the methods utilize pharmaceutical compositions containing certain compounds having an anti-inflanumatory and anti-oxidant moiety covalently linked by thiol or sulfoxide or sulfone bond. The compounds are useflil in preventing and treating inflammatory disorders through several mechanisms.
REFERENCES:
patent: 4645845 (1987-02-01), Gehrken et al.
patent: 5484810 (1996-01-01), Grisar et al.
patent: 5607966 (1997-03-01), Hellberg et al.
patent: 5643943 (1997-07-01), Gamache et al.
patent: 5811438 (1998-09-01), Hellberg et al.
Bellavite, P., "The Superoxide-Forming Enzymatic System Of Phagocytes", Free Radical Biology & Medicine, vol. 4, pp. 225-261 (1988).
Bonne, C. et al., 2-(2-Hydroxy-4-methylphenyl)aminothiazole Hydrochloride as a Dual Inhibitor of Cyclooxygenase/Lipoxygenase and a Free Radical Scavenger, Drug Research, vol. 39(II), No. 10, pp. 1242-1250 (1989).
Campbell, W., "Lipid-Derived Autacoids: Eicosanoids And Platelet-Activiating Factor", Goodman and Gilman's The Pharmacological Basis of Therapeutics, Pergman Press, NY, pp. 600-617 (1990).
Carew, Proceedings of the National Academy of Science, U.S.A., vol. 84, pp. 7725-7729 (1989).
Cherfan, G.M., et al., Nuclear Sclerotic Cataract After Vitrectomy for Idiopathic Epiretinal Membranes Causing Macular Pucker, American Journal Of Ophthalmology, vol. 111, pp. 434-438 (1991).
Chow, C., "Vitamin E And Oxidative Stress", Free Radical Biology & Medicine, vol. II, pp. 215-232 (1991).
Dobbs, R.E., et al., Evaluation Of Lens Changes In Idiopathic Epiretinal Membrane, vol. 5, Nos. 1 & 2, pp. 143-148 (1988).
Duchstein, H. et al., "Activiated Species of Oxygen: A Challenge to Modern Pharmaceutical Chemistry", Archives of Pharmacology, vol. 325, pp. 129-146 (1992).
Duniec, Z. et al.; "Antioxidant properties of some chemicals vs their influence on cyclooxygenase and lipoxidase activities", Biochemical Pharmacology, vol. 32, No. 14, pp. 2283-2286 (1983).
Gifford, H., "On The Treatment Of Sympathetic Ophthalmia By Large Doses Of Salicylate Of Sodium, Aspirin, Or Other Salicylic Compounds", Ophthalmoscope, vol. 8, pp. 257-259 (1910).
Guo, A., et al., Effects of anti-inflammatory and immunosuppressive drugs on the heterolamellar corneal transplantation in rabbits, Current Eye Research, vol. 9, No. 8, pp. 749-757 (1990). Human Disease: An Overview", Methods in Enzymology, vol. 186, pp. 1-85 (1990).
Insel, P., "Analgesic-Antipyretics And Antiinflammatory Agents: Drugs Employed In The Treatment Of Rheumatoid Arthritis And Gout", Goodman and Gilman's The Pharmacological Basis of Therapeutics, Pergman Press, NY, pp. 638-669 and 681 (1990).
Kreiger, A.E., Wound Complications In Pars Plana Vitrectomy, Retina, vol. 13, No. 4, pp. 335-344 (1993).
Lindstrom, R.L., et al., Corneal Preservation at 4.degree. C. with Chondroitin Sulfate-Containing Medium, The Cornea: Transactions of the World Congress on the Cornea III, edited by H. Dwight Cavanagh, Raven Press, Ltd., New York, Chapter 14, pp. 81-89 (1988).
Momsen, W. et al., "Lipid Structural Reorganization Induced by the Pancreatic Lipase Cofactor, Procolipase", Biochemistry, vol. 34, pp. 7271-7281 (1995).
Nelson, P., "Cyclooxygenase Inhibitors", CRC Handbook of Eicosanoids: Prostaglandins and Related Lipids, vol. II, Drugs Acting Via the Eicosanoids, CRC Press, Boca Raton, FL, pp. 59-133 (1989).
Parinandi et al., Arch Biochem Biophys, vol. 28, pp. 45-52 (1990).
Petty, M., et al.; "Protective effects of an .alpha.-tocopherol analogue against myocardial reperfusion injury in rats", European Journal of Pharmacology, vol. 210, pp. 85-90 (1992).
PJB, Scrip No., 1574:31 (1990).
Rainsford, K.D., editor, Inflammation and Mechanism and Actions of Traditional Drugs, vol. 1 Anti-inflammatory and Anti-rheumatic drugs, Boca Raton, FL, CRC Press, pp. 54-68, 79-87, 120-126 and 140-144 (1985).
Stampfer, M., et al.; "Vitamin E Consumption and the Risk of Coronary Disease in Women", New England Journal of Medicine, vol. 328, No. 20, pp. 1444-1449 (1993).
Steinberg, D., et al.; "Lipoprotein and Atherogenesis", JAMA, vol. 264, No. 3, pp. 3047-3052 (1990).
Thompson, J.T., et al., Progression of Nuclear Sclerosis and Long-term Visual Results of Vitrectomy With Transforming Growth Factor Beta-2 for Macular Holes, American Journal Of Ophthalmology, vol. 119, pp. 48-54 (1995).
Rimm, E., et al.; "Vitamin E Consumption and the Risk of Coronary Heart Disease in Men", New England Journal of Medicine, vol. 328, No. 20, pp. 1450-1456 (1993).
Sies, H., et al.; "Role of tocopherols in the protection of biological systems against oxidative damage", Journal of Photochemistry and Photobiology, vol. 8, pp. 211-224 (1991).
Smaby, J. M., et al., "Characterization of Lipid Miscibiity in Liquid-Expanded Monolayers at the Gas-Liquid Interface", Langmuir, vol. 8, No. 2, pp. 563-570 (1992).
Vane, J., et al., "Inflammation and the mechanism of action of anti-inflammatory drugs", FASEB Journal, vol. 1, pp. 89-96 (1987).
Hellberg Mark R.
Namil Abdelmoula
Nixon Jon C.
Alcon Laboratories Inc.
Mayo Michael C.
Owens Amelia
LandOfFree
Benzofurans and benzopyrans as cytoprotective agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzofurans and benzopyrans as cytoprotective agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzofurans and benzopyrans as cytoprotective agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1322279